Design, synthesis, multifunctionalization and biomedical applications of multifunctional mesoporous silica-based drug delivery nanosystems. ([2016])
- Record Type:
- Book
- Title:
- Design, synthesis, multifunctionalization and biomedical applications of multifunctional mesoporous silica-based drug delivery nanosystems. ([2016])
- Main Title:
- Design, synthesis, multifunctionalization and biomedical applications of multifunctional mesoporous silica-based drug delivery nanosystems
- Further Information:
- Note: Yu Chen.
- Authors:
- Chen, Yu
- Contents:
- Supervisor's Foreword; Acknowledgments; Contents; 1 Research Background; 1.1 Introduction; 1.2 Synthetic Methodologies and Structures of Mesoporous Materials; 1.2.1 Formation Mechanism of Mesoporous Materials; 1.2.2 Structures of Mesoporous Materials; 1.3 Biomedical Applications of Mesoporous Materials; 1.3.1 Mesoporous Materials for Drug Loading and Sustained Release; 1.3.2 Mesoporous Materials for Controlled Drug Releasing; 1.3.3 Mesoporous Materials for Photodynamic Therapy; 1.3.4 Mesoporous Materials for Synergistic Therapy; 1.3.5 MSNs for Targeted Drug Delivery. 1.3.6 Mesoporous Materials for Theranostic Applications1.3.6.1 Magnetic Resonance Imaging (MRI); 1.3.6.2 Fluorescent Imaging; 1.3.6.3 Multi-modality Diagnostic Imaging; 1.4 The Development Trends of Mesoporous Materials; 1.5 Significance of this Thesis; References; 2 Synthesis of Hollow Mesoporous Silica Nanoparticles by Silica-Etching Chemistry for Biomedical Applications; 2.1 Introduction; 2.2 Experimental Section; 2.2.1 Synthesis of HMSNs Based on SDSE Strategy; 2.2.2 Synthesis of HMSNs by Chemical Etching in Ammonia Solution; 2.2.3 Study of the Formation Mechanism of HMSNs. 2.2.4 Synthesis of Multifunctional Rattle-Type HMSNs Based on SDSE Strategy2.2.5 Hemolytic Effect Evaluation; 2.2.6 In Vitro DOX-Loading into HMSNs; 2.2.7 MTT Evaluation of the Cytotoxicity of HMSNs and DOX-HMSNs; 2.3 Results and Discussion; 2.3.1 Synthesis and Characterization of HMSNs; 2.3.2 Synthesis of Multifunctional M@mSiO2Supervisor's Foreword; Acknowledgments; Contents; 1 Research Background; 1.1 Introduction; 1.2 Synthetic Methodologies and Structures of Mesoporous Materials; 1.2.1 Formation Mechanism of Mesoporous Materials; 1.2.2 Structures of Mesoporous Materials; 1.3 Biomedical Applications of Mesoporous Materials; 1.3.1 Mesoporous Materials for Drug Loading and Sustained Release; 1.3.2 Mesoporous Materials for Controlled Drug Releasing; 1.3.3 Mesoporous Materials for Photodynamic Therapy; 1.3.4 Mesoporous Materials for Synergistic Therapy; 1.3.5 MSNs for Targeted Drug Delivery. 1.3.6 Mesoporous Materials for Theranostic Applications1.3.6.1 Magnetic Resonance Imaging (MRI); 1.3.6.2 Fluorescent Imaging; 1.3.6.3 Multi-modality Diagnostic Imaging; 1.4 The Development Trends of Mesoporous Materials; 1.5 Significance of this Thesis; References; 2 Synthesis of Hollow Mesoporous Silica Nanoparticles by Silica-Etching Chemistry for Biomedical Applications; 2.1 Introduction; 2.2 Experimental Section; 2.2.1 Synthesis of HMSNs Based on SDSE Strategy; 2.2.2 Synthesis of HMSNs by Chemical Etching in Ammonia Solution; 2.2.3 Study of the Formation Mechanism of HMSNs. 2.2.4 Synthesis of Multifunctional Rattle-Type HMSNs Based on SDSE Strategy2.2.5 Hemolytic Effect Evaluation; 2.2.6 In Vitro DOX-Loading into HMSNs; 2.2.7 MTT Evaluation of the Cytotoxicity of HMSNs and DOX-HMSNs; 2.3 Results and Discussion; 2.3.1 Synthesis and Characterization of HMSNs; 2.3.2 Synthesis of Multifunctional M@mSiO2 Nanorattles; 2.3.3 HMSNs for Anticancer Drug Delivery; 2.4 Conclusions; References; 3 Multifunctional Mesoporous Silica Nanoparticles for Theranostics of Cancer; 3.1 Introduction; 3.2 Experimental Section; 3.2.1 Synthesis of Fe3O4@mSiO2. 3.2.2 Synthesis of Gd-Si-DPTA-Au@mSiO23.2.3 Blood Compatibility of Fe3O4@mSiO2; 3.2.4 In Vitro Cytotoxicity of Fe3O4@mSiO2 Nanocapsules; 3.2.5 Drug-Loading and Anticancer Efficiency; 3.2.6 CLSM Observations of the Cell Internalization of Fe3O4@mSiO2 Nanocapsules; 3.2.7 Bio-TEM Observations; 3.2.8 In Vitro and In Vivo MR Imaging; 3.2.9 Dark-Field Microscopic Labeling of HeLa Cancer Cells; 3.3 Results and Discussion; 3.3.1 Synthesis of Characterization of Fe3O4@mSiO2; 3.3.2 Magnetic Fe3O4@mSiO2 for MRI and Anticancer Drug Delivery. 3.3.3 Synthesis of Gd-Si-DTPA-Grafted Au@mSiO2 for Biomedical Applications3.4 Conclusions; References; 4 Hollow Mesoporous Silica Nanoparticles for Ultrasound-Based Cancer Diagnosis and Therapy; 4.1 Introduction; 4.2 Experimental Section; 4.2.1 Material Synthesis; 4.2.2 In Vitro MRI Evaluation; 4.2.3 Ex Vivo Evaluation Toward the HIFU Synergistic Effect of IMNCs, PFH-IMNCs, MCNCs, and PFH-MCNCs; 4.2.4 CLSM Observation of Intracellular Uptake and Location of RITC-MCNCs. … (more)
- Publisher Details:
- Heidelberg : Springer
- Publication Date:
- 2016
- Extent:
- 1 online resource
- Subjects:
- 615.6
Drug delivery systems
Nanoparticles
Mesoporous materials
MEDICAL -- Pharmacology
Drug delivery systems
Mesoporous materials
Nanoparticles
Materials Science
Biomaterials
Cancer Research
Biomedical Engineering
Drug Delivery Systems
Nanoparticles
Electronic books - Languages:
- English
- ISBNs:
- 9783662486221
3662486229 - Related ISBNs:
- 9783662486207
3662486202
9783662486207 - Notes:
- Note: Includes bibliographical references.
Note: Online resource; title from PDF title page (EBSCO, viewed October 27, 2015). - Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.401234
- Ingest File:
- 02_440.xml